ClinicalTrials.gg
RecruitingNCT06166199SLE-HIITUpdated Dec 12, 2023

Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus

An interventional study of HIIT combined with resistance training in Lupus Erythematosus, Systemic, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-12.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Nov 2022, registered Nov 2023).
  • Started Nov 2022; still recruiting 4 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Lupus Erythematosus, Systemic with a site in Sweden — 6 open to participants now, 10 under way, 2 of them phase 3. Lupus Erythematosus, Systemic · Sweden.

Planned enrollment
12th of 13
40 · median 275
Started
2022
with 2 others
No phase
2 of 19
2 open now
Registered
14th of 19
by date
Lead sponsor
2 of 19
Karolinska Institutet

Among the 19 studies in Lupus Erythematosus, Systemic with a site in Sweden, this one is the 12th largest by planned enrollment of the 13 interventional ones that give a count, is one of 3 that started in 2022, is one of 2 with no phase, and was the 14th registered.

Lupus Erythematosus, Systemic

1,211 studies on the registry are indexed under Lupus Erythematosus, Systemic; 406 are open to participants now.

Browse Lupus Erythematosus, Systemic studies →

Open to participants now

6 of the 19 studies in Lupus Erythematosus, Systemic with a site in Sweden are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 284 Lupus Erythematosus, Systemic studies recruiting now, 94 (33%) set no upper age limit and 160 (56%) stop at 75 or younger; 54 take children under 18; 32 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Lupus Erythematosus, Systemic with a site in Sweden, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the safety and effects of high-intensity interval training (HIIT) combined with resistance training in patients with systemic lupus erythematosus

Read the detailed description

The overall aim of this randomized controlled study, is to evaluate the safety and effects of HIIT combined with resistance exercises on aerobic capacity, muscle function, patient reported outcomes, disease activity and immune function in patients with SLE with low to moderate disease activity and no to little organ damage. The aim is also to explore and describe patient's experiences of the training.

The research questions are:

  1. What are the differences between the HIIT combined with resistance exercises and a control group, after 3 months of supervised training and after further 3 months of self training with video-call/telephone support until 6 months follow up, regarding aerobic capacity, muscle function, physician and patient reported disease activity, fatigue, depressive symptoms, and quality of life?
  2. What are the differences between the HIIT combined with resistance exercises and a control group, after 3 months of supervised training and after further 3 months of self training with video-call/telephone support until 6 months follow up, regarding inflammatory markers such as interleukin 6 and 10 and interferon molecules? Both acute exercise test (maximal ergometercycle test) effects as well as the long term effects of training will be evaluated.
  3. How do individuals with SLE experience HIIT combined with resistance exercises ? What are the perceived barriers and facilitators for performing and maintaining such training?
03

Conditions studied

  • Lupus Erythematosus, Systemic

Keywords

  • Physical exercise
  • High-intensity interval training
  • Resistance training
  • Quality of life
  • Aerobic capacity
  • Fatigue
  • Disease activity
  • Patients experiences
  • Inflammatory markers
  • Muscle function
  • Depressive symptoms
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥18 years old
  • Fulfilment of the 1982 American College of Rheumatology (ACR) criteria; or 2012 Systemic Lupus International Collaborating Clinics (SLICC/ACR-Damage Index (DI)) classification criteria; or EULAR/ACR criteria; or patients that have received the diagnosis SLE on clinical grounds
  • Low to moderate disease activity, for example defined as a score of ≤5 in the clinical version of the SLE Disease Activity Index 2000 (SLEDAI-2K), i.e., excluding the serological descriptors (anti-dsDNA positivity and low complement levels)
  • Low/minimal or no organ damage, for example defined as a score of ≤3 in the SLICC/ACR DI
  • Stable pharmacological treatment
  • The ability to perform a maximal ergometercycle exercise test
  • Be able to read and understand Swedish

Exclusion criteria

Exclusion Criteria:

  • Symptoms or signs of cerebro-vascular disease, pulmonary embolus, pulmonary hypertension, pulmonary fibrosis, cardiovascular disease, angina pectoris, myocardial infarction, dyspnea at rest, uncontrolled blood pressure and uncontrolled diabetes within one year prior to study entry. Chronic kidney disease with
  • Patients who fulfil the absolute for maximal exercise testing according to American Heart Association
  • Patients who cannot perform a maximal ergometercycle exercise test due to the disease
  • Diseases or other conditions that strongly reduce the ability to exercise or that exercise is not recommended
  • Patients who perform regular aerobic fitness training and muscle strength exercise sessions at fixed times, >1 time/week
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    High-intensity interval training (HIIT) combined with resistance training

    Patients with SLE will undergo supervised HIIT on an ergometercycle 4 x 4 minutes interval (85-90% of maximal heart rate in 4 minutes and lower intensity for another 4 minutes etc). The HIIT is combined with resistance exercises for upper and lower extremity. In total the supervised training takes around 50 minutes per occasion and will be performed 2 times/week, for 3 months. In addition, the patients will exercise, according to the program, by themselves once a week. Between months 3 and 6 the patients exercise by themselves, 3 times/week, with video-call/telephone support from a physiotherapist once a week.

    Behavioral: HIIT combined with resistance training

  • No intervention
    Control group

    Both the control group and the HIIT combined with resistance training group receive standard care.

Interventions

  • BehavioralHIIT combined with resistance training

    Patients with SLE will undergo supervised HIIT on an ergometercycle, 4 x 4 minutes interval, (85-90% of maximal heart rate in 4 minutes and lower intensity for another 4 minutes etc). The HIIT is combined with resistance exercises for upper and lower extremity. In total the training takes around 50 minutes per occasion and will be performed 2 times/week, for 3 months. In addition, the patients will exercise, according to the program, by themselves once a week. Between months 3 and 6 the patients exercise by themselves, 3 times/week, with video-call/telephone support from a physiotherapist once a week.

06

What researchers measure

Primary outcomes

  1. Aerobic capacity

    Aerobic capacity is measured as maximal oxygen uptake when performing a maximal symptom-limited, ergometercycle exercise test

    Time frame: Baseline, months 3 and 6

  2. Physical capacity

    Physical capacity are measured when performing a symptom-limited, ergometercycle exercise test

    Time frame: Baseline, months 3 and 6

Secondary outcomes

  1. Muscle function upper extremity

    How many shoulder flexions (0-90 degrees), in a given pace, with a 3 kg (men) or 2 kg (women) dumbbell in the hand is possible to do

    Time frame: Baseline, months 3 and 6

  2. Self-reported disease activity

    The patient-reported questionnaire Systemic Lupus Erythematosus Activity Questionnaire includes three parts. The part about disease symptoms goes from 0-47 points, the higher the points the more disease symptoms. Further there is a question about flares with four answer alternatives, from no flares to serious flares. There is also a numerical rating scale about disease activity on a scale from 0-10, the higher value the higher the disease activity

    Time frame: Baseline, months 3 and 6

  3. Fatigue

    The patient-reported questionnaire Functional Assessment of Chronic Illness Therapy, FACIT-Fatigue goes from 0-52 points, the higher the value, the less the fatigue

    Time frame: Baseline, months 3 and 6

  4. Anxiety and depressive symptoms

    The patient-reported questionnaire Hospital Anxiety and Depression scale goes from 0-21 points, the higher the value, the higher the anxiety and depressive symptoms. In the anxiety and depressive symptoms subscales the points goes from 0-6, the higher the value, the higher anxiety and depressive symptoms respectively

    Time frame: Baseline, months 3 and 6

  5. Quality of life in SLE

    The patient-reported questionnaire Lupus Quality of life questionnaire goes from 0-100 points, the higher the value the better the quality of life

    Time frame: Baseline, months 3 and 6

  6. Generic Quality of life

    The patient-reported questionnaire Short Form Health Survey (SF-36). Each subscale goes from 0-100 points, the higher the value, the higher the quality of life.

    Time frame: Baseline, months 3 and 6

  7. Quality of life and health status

    The patient-reported questionnaire EuroQol 5-dimensions (EQ-5D). The index scores goes from -0,594 till 1,000, the higher the value, the higher the quality of life

    Time frame: Baseline, months 3 and 6

  8. Disease activity

    SLE Disease Activity Index 2000 (SLEDAI-2K) assessed by a physician, goes from 0-105 points, the higher the value, the higher the disease activity

    Time frame: Baseline, months 3 and 6

  9. Inflammatory markers

    Blood samples are collected before and after maximal ergometercycle exercise test

    Time frame: Baseline, months 3 and 6

  10. Health status

    The patient-reported questionnaire EuroQol 5-dimensions (EQ-5D)-5L Visual analogue scale, 0-100 mm, the higher the value, the better the health

    Time frame: Baseline, months 3 and 6

  11. Blood pressure

    Resting diastolic and systolic blood pressure

    Time frame: Baseline, month 3 and 6

Other outcomes

  1. Organ damage

    Systemic Lupus International Collaborating Clinics (SLICC/ACR-Damage Index). Organ damage last 6 months, assessed by a physician. The points goes from 0-47, the higher the value, the more organ damage

    Time frame: Baseline and 6 months

  2. Demographical, clinical and lifestyle behaviour data including age, gender, ethnic origin, and smoking status as well as other for the project important information about the disease such as autoantibody profiles and pharmacological treatment

    A questionnaire developed specific for this project and data from patients medical files

    Time frame: Baseline. For some variables, such as medical treatment, also months 3 and 6

  3. Physical activity

    The patient-reported questionnaire International Physical Activity Questionnaire addresses the number of days and time spent on physical activity in moderate intensity, vigorous intensity and walking of at least 10-min duration the last 7 days, and also includes time spent sitting on weekdays the last 7 days. The sum score is expressed in physical activity Metabolic Equivalent of Task-minutes per day or week

    Time frame: Baseline, months 3 and 6

  4. Activity-minutes and sitting behaviour

    The patient-reported questions about Activity-minutes and sitting behaviour according to the Swedish National Board of Health and Welfare. For the two questions about physical training and exercise with 5 respective 6 answer alternatives, the higher the value, the more time spending training and exercising. The question about sitting have 7 answer alternatives, the higher the value, the less time spent sitting

    Time frame: Baseline, months 3 and 6

  5. Weight

    Weight in kilograms

    Time frame: Baseline, months 3 and 6

  6. Height

    Height in meters

    Time frame: Baseline

  7. Body Mass Index (BMI)

    Weight in kilograms divided by the height in metres squared

    Time frame: Baseline, months 3 and 6

  8. Muscle function lower extremity

    How many times is it possible to raise from a chair during 30 seconds; the "30 seconds Chair stand test"

    Time frame: Baseline, months 3 and 6

07

Study locations

1 of 1 sites recruiting
  • Carina Boström
    Stockholm, Huddinge 141 83, Sweden
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2022 (actual). Primary completion is estimated for Jun 2025, 31 months after the start.

Of 123 non-industry interventional studies with no phase under Lupus Erythematosus, Systemic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 31 months is above that.

Counting every sponsor, half of 130 studies reached it within 23 months; a quarter within 10 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 22, 2023
First posted
Dec 12, 2023
StartActual
Nov 1, 2022
Primary completionEst.
Jun 30, 2025
CompletionEst.
Dec 31, 2026
Last update
Dec 12, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06166199
Collaborators
Swedish Rheumatism Association, Region Örebro County, County Council of Norrbotten, Sweden, Karolinska University Hospital
Responsible party
Carina Boström (Associate professor, university lecturer, Karolinska Institutet) — Principal investigator
First posted
Dec 12, 2023
Start date
Nov 1, 2022
Primary completion
Jun 30, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Dec 12, 2023

Study contacts

Carina M Boström, Dr
Contact
carina.bostrom@ki.se
046 0722006321
Ioannis Parodis, Dr
Contact
ioannis.parodis@ki.se
046 0722321322
Carina M Boström, Dr
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion